Mechanism of Growth Hormone Effects on Adipose Tissue
NCT00453557 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2016-12-08
Summary
Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.
Conditions
Interventions
- DRUG
-
rhGH
Sponsors & Collaborators
-
Pennington Biomedical Research Center
lead OTHER
Principal Investigators
-
Steven R Smith, M.D. · Pennington Biomedical Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-04-30
- Primary Completion
- 2000-12-31
- Completion
- 2000-12-31
Countries
- United States
Study Locations
More Related Trials
-
Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
NCT00517062 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
NCT00720616 ·Status: WITHDRAWN ·Phase: NA
-
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 ·Status: COMPLETED ·Phase: NA
-
Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls
NCT01169103 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults
NCT00352287 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
NCT00562796 ·Status: COMPLETED
-
Consequence of Lifetime Isolated Growth Hormone Deficiency
NCT00149708 ·Status: COMPLETED ·Phase: NA
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Growth Hormone Signaling in Vivo in Humans
NCT00512473 ·Status: COMPLETED ·Phase: NA
-
Effects of GH and Lirglutide on AgRP
NCT05681299 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
NCT00120497 ·Status: UNKNOWN
-
Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)
NCT01020955 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Respiratory Training Protocols on GH Secretion in Obesity (ALRESPGHOB)
NCT05759598 ·Status: TERMINATED ·Phase: NA
-
Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
NCT01616095 ·Status: COMPLETED
-
Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting
NCT02500095 ·Status: COMPLETED ·Phase: NA
-
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
NCT00140842 ·Status: COMPLETED
-
rhGH Therapy on Hepatic Drug Metabolism
NCT00458991 ·Status: COMPLETED
-
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
NCT00131378 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
NCT00490191 ·Status: COMPLETED ·Phase: PHASE4
-
Lipolytic Effects of GH in Hypopituitary Patients in Vivo
NCT02782208 ·Status: COMPLETED ·Phase: NA
-
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
NCT03225755 ·Status: COMPLETED
-
IGF1 Generation Test
NCT00145457 ·Status: COMPLETED ·Phase: PHASE4
-
Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
NCT02726542 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old
NCT01853566 ·Status: COMPLETED ·Phase: PHASE4